HealthEquity Statistics
Total Valuation
HealthEquity has a market cap or net worth of $6.94 billion. The enterprise value is $7.62 billion.
| Market Cap | 6.94B |
| Enterprise Value | 7.62B |
Important Dates
The last earnings date was Tuesday, March 17, 2026, after market close.
| Earnings Date | Mar 17, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HealthEquity has 84.48 million shares outstanding. The number of shares has decreased by -1.53% in one year.
| Current Share Class | 84.48M |
| Shares Outstanding | 84.48M |
| Shares Change (YoY) | -1.53% |
| Shares Change (QoQ) | -0.78% |
| Owned by Insiders (%) | 1.89% |
| Owned by Institutions (%) | 107.63% |
| Float | 82.85M |
Valuation Ratios
The trailing PE ratio is 33.37 and the forward PE ratio is 17.76. HealthEquity's PEG ratio is 1.30.
| PE Ratio | 33.37 |
| Forward PE | 17.76 |
| PS Ratio | 5.28 |
| Forward PS | 4.88 |
| PB Ratio | 3.31 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 15.24 |
| P/OCF Ratio | 15.17 |
| PEG Ratio | 1.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.80, with an EV/FCF ratio of 16.74.
| EV / Earnings | 35.40 |
| EV / Sales | 5.80 |
| EV / EBITDA | 15.80 |
| EV / EBIT | 23.26 |
| EV / FCF | 16.74 |
Financial Position
The company has a current ratio of 3.27, with a Debt / Equity ratio of 0.48.
| Current Ratio | 3.27 |
| Quick Ratio | 2.82 |
| Debt / Equity | 0.48 |
| Debt / EBITDA | 2.06 |
| Debt / FCF | 2.20 |
| Interest Coverage | 5.73 |
Financial Efficiency
Return on equity (ROE) is 10.19% and return on invested capital (ROIC) is 9.00%.
| Return on Equity (ROE) | 10.19% |
| Return on Assets (ROA) | 5.99% |
| Return on Invested Capital (ROIC) | 9.00% |
| Return on Capital Employed (ROCE) | 10.16% |
| Weighted Average Cost of Capital (WACC) | 5.80% |
| Revenue Per Employee | $420,971 |
| Profits Per Employee | $68,975 |
| Employee Count | 3,120 |
| Asset Turnover | 0.38 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, HealthEquity has paid $62.23 million in taxes.
| Income Tax | 62.23M |
| Effective Tax Rate | 22.43% |
Stock Price Statistics
The stock price has decreased by -3.28% in the last 52 weeks. The beta is 0.32, so HealthEquity's price volatility has been lower than the market average.
| Beta (5Y) | 0.32 |
| 52-Week Price Change | -3.28% |
| 50-Day Moving Average | 80.41 |
| 200-Day Moving Average | 92.06 |
| Relative Strength Index (RSI) | 57.97 |
| Average Volume (20 Days) | 949,409 |
Short Selling Information
The latest short interest is 3.23 million, so 3.82% of the outstanding shares have been sold short.
| Short Interest | 3.23M |
| Short Previous Month | 3.17M |
| Short % of Shares Out | 3.82% |
| Short % of Float | 3.90% |
| Short Ratio (days to cover) | 3.32 |
Income Statement
In the last 12 months, HealthEquity had revenue of $1.31 billion and earned $215.20 million in profits. Earnings per share was $2.46.
| Revenue | 1.31B |
| Gross Profit | 913.12M |
| Operating Income | 327.48M |
| Pretax Income | 277.43M |
| Net Income | 215.20M |
| EBITDA | 482.14M |
| EBIT | 327.48M |
| Earnings Per Share (EPS) | $2.46 |
Balance Sheet
The company has $318.93 million in cash and $1.00 billion in debt, with a net cash position of -$682.55 million or -$8.08 per share.
| Cash & Cash Equivalents | 318.93M |
| Total Debt | 1.00B |
| Net Cash | -682.55M |
| Net Cash Per Share | -$8.08 |
| Equity (Book Value) | 2.11B |
| Book Value Per Share | 24.79 |
| Working Capital | 355.43M |
Cash Flow
In the last 12 months, operating cash flow was $457.09 million and capital expenditures -$1.97 million, giving a free cash flow of $455.13 million.
| Operating Cash Flow | 457.09M |
| Capital Expenditures | -1.97M |
| Depreciation & Amortization | 154.66M |
| Net Borrowing | -100.00M |
| Free Cash Flow | 455.13M |
| FCF Per Share | $5.39 |
Margins
Gross margin is 69.52%, with operating and profit margins of 24.93% and 16.38%.
| Gross Margin | 69.52% |
| Operating Margin | 24.93% |
| Pretax Margin | 21.12% |
| Profit Margin | 16.38% |
| EBITDA Margin | 36.71% |
| EBIT Margin | 24.93% |
| FCF Margin | 34.65% |
Dividends & Yields
HealthEquity does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.53% |
| Shareholder Yield | 1.53% |
| Earnings Yield | 3.10% |
| FCF Yield | 6.56% |
Analyst Forecast
The average price target for HealthEquity is $114.64, which is 39.64% higher than the current price. The consensus rating is "Buy".
| Price Target | $114.64 |
| Price Target Difference | 39.64% |
| Analyst Consensus | Buy |
| Analyst Count | 14 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HealthEquity has an Altman Z-Score of 4.8 and a Piotroski F-Score of 8.
| Altman Z-Score | 4.8 |
| Piotroski F-Score | 8 |